Twist Bioscience
GenomeWeb Top 40 Down 4 Percent in February, Tracking Broader Market
The Dow Jones Industrial Average was down 4 percent, while the Nasdaq was down 1 percent, and the Nasdaq Biotech Index was down 7 percent.
Twist Bioscience Shares Fall 17 Percent as Fiscal Q2 Guidance Comes In Below Wall Street Estimates
Twist provided fiscal second quarter revenue guidance of approximately $56.5 million, with $24 million in synbio revenues and $25 million in NGS revenues.
New Products Posted to GenomeWeb: Twist Bioscience, Centogene, Juno Diagnostics, Bio-Techne, More
New products and services posted to GenomeWeb for the week of Jan. 9, 2023.
JP Morgan Healthcare Conference, Day 1: Guardant Health, Exact Sciences, Bruker, 10x Genomics, More
Highlights from the first day included Exact Sciences' profitability forecast, an update on QuidelOrtho's integration, and Guardant Health's "quantum leap forward" with its "smart" liquid biopsy platform.
Twist Bioscience Shares Upgraded to Outperform by Evercore ISI
Evercore cited the synthetic DNA maker's response to a recent report from a short seller that dragged down its shares toward the end of 2022.
Oct 14, 2022